Coptis teeta Wall.: A Comprehensive Overview of its Traditional Uses, Pharmacological Uses, Phytochemicals and Conservation

Abstract

Coptis teeta Wall. (C. teeta) is a herb that goes by the name “Mishmi Tita”, and holds significant value as a medicinal plant for treating various health conditions. This endangered plant, listed in the Red Data Book, is commonly found in India, Nepal, Bhutan and China. The present review aims to comprehensively summarize the traditional, pharmaceutical, and phytochemical aspects of C. teeta, providing a foundation for researchers to explore this endangered plant, and take bold steps to conserve, cultivate, and promote awareness among local people. A thorough literature search was conducted on PubMed, Google Scholar, Research Gate, SciFinder, and the ISI Web of Knowledge, using the following terms: “Coptis teeta”, “Coptis teeta Wall.”, “Mishmi tita”, “Rhizoma coptidis”, “Chinese medicine from Coptis teeta”, and “Traditional uses of Coptis teeta”. A comprehensive examination of 69 articles published between 1982 and 2023 was conducted to explore the properties and traditional applications of C. teeta. It was found that this plant and its active compounds exhibit a range of effects, such as fighting against microbes, alleviating diarrhoea, lowering blood pressure, regulating heart rhythm, reducing inflammation, improving mood, treating trachoma, managing diabetes, providing pain relief, and countering reactions. A total of 27 compounds were identified in different parts of this plant, according to the surveyed literature. These have been traditionally utilized to address ailments, including conditions, eye disorders, skin issues, gastrointestinal troubles like constipation and jaundice, and urinary disorders. Furthermore, these have shown potential in cancer treatment and mitigating inflammation. C. teeta boasts diverse traditional uses and promising pharmacological activities due to its rich chemical composition. Berberine is the main constituent, and various communities utilize it for various ailments. While endangered, C. teeta offers exciting medicinal potential, warranting further research and sustainable conservation efforts. Cultivating the plant and raising public awareness are crucial steps towards its preservation.

Keywords

Coptis teeta Wall. / Traditional uses / Pharmaceutical uses / Phytochemis-try / Pharmacological activities / Conservation

Acknowledgments

The authors would like to thank the Director of CSIR-North East Institute of Science & Technology, Jorhat, Assam, India for the valuable advice and support.

Funding

This study was supported by SEED Division, DST New Delhi (Grant no. DST/SEEDS/ TSP/STI/2020/266).

Conflict of interest

There is no conflict of interest to declare.

Author contributions

Drafting of the manuscript (NC, HS, CT), collection of data (NC, HS, CT), compilation of data (NC, HS) and correction of manu-script (CT). All authors have made a significant contribution to this study and have approved the final manuscript.

References

[1] Xiang KL, Wu SD, Yu SX, Liu Y, Jabbour F, Erst AS, et al. The First Com-prehensive Phylogeny of Coptis (Ranunculaceae) and Its Implica-tions for Character Evolution and Classification. PLoS One 2016; 11(4):e0153127. doi:10.1371/journal.pone.0153127,PMID:27044035.

[2] Wang J, Wang L, Lou GH, Zeng HR, Hu J, Huang QW, et al. Coptidis Rhi-zoma: a comprehensive review of its traditional uses, botany, phyto-chemistry, pharmacology and toxicology. Pharm Biol 2019; 57(1):193-225. doi:10.1080/13880209.2019.1577466,PMID:30963783.

[3] Haridasan K, Bhuyan LR. Ethnobotanical observations on bioresource management in Northeast India. J Tradit Folk Practices 2016; 2, 3 & 4(1):18-32.

[4] Bajpay A, Nainwal RC, Singh D. Coptis teeta: A potential endemic and endangered medicinal plant of Eastern Himalayas. J Pharmacogn Phytochem 2019; 8(4):245-248.

[5] Mukherjee D. Study of morphology and outcome of various show-ing measures with organic nutrient application on newly introduced plant Coptis teeta (rare plant in earth) in Darjeeling hills. J Med Plants Stud 2016; 4(5):186-188.

[6] Huang J, Long C. Traditional cultivation of Coptis teeta and its values in biodiversity conservation. Biodivers Sci 2006; 14(1):79-86.

[7] Gupta R, Gupta J. Rare and Endangered Plant Species with Potential Remedial Outcomes of Coptis teeta: An Updated Review. Bull Env Pharmacol Life Sci 2020; 9(10):01-05.

[8] Ali N, Ghosh B. Ethnomedicinal Plants In Arunachal Pradesh: Some Tacit Prospects. Envis Bulletin, Himalayan Ecology 2006; 14(2):22-28.

[9] Khongsai M, Saikia SP, Kayang H. Ethnomedicinal Plants used by different tribes of Arunachal Pradesh. Indian J Tradit Knowl 2011; 10(3):541-546.

[10] Murtem G, Chaudhry P. An Ethnobotanical Study of Medicinal Plants Used by the Tribes in Upper Subansiri District of Arunachal Pradesh, India. Am J Ethnomed 2016; 3(3):35-49.

[11] Rethy P, Singh B, Kagyung R, Gajurel PR. Ethnobotanical studies of Dehang-Debang Biosphere Reserve of Arunachal Pradesh with spe-cial reference to Memba tribe. Indian J Tradit Knowl 2010; 9(1):61-67.

[12] Tangjang S, Namsa ND, Aran C, Litin A. An ethnobotanical survey of medicinal plants in the Eastern Himalayan zone of Arunachal Pradesh, India. J Ethnopharmacol 2011; 134(1):18-25. doi:10.1016/j.jep.2010.11.053, PMID:21129478.

[13] Tripathi AK, Limasenla, Shankar R. Ethno-Medicinal Plants used by Nyishi Tribe of Arunachal Pradesh, India. World J Pharm Pharm Sci 2017; 6(5):1246-1253. doi:10.20959/wjpps20175-9213.

[14] Bushi D, Bam K, Mahato R, Nimasow G, Nimasow OD, Tag H. Eth-nomedicinal plants used by the indigenous tribal communities of Arunachal Pradesh, India: a review. Ethnobot Res Appl 2021; 22:1-40. doi:10.32859/era.22.34.1-40.

[15] Temin Payum. Distribution, Ethnobotany, Pharmacognosy and Phyto-constituents of Coptis teeta Wall. Pharmacogn J 2017; 9(6s):s28-s34. doi:10.5530/pj.2017.6s.154.

[16] Srivastava RC, Nyishi Community. Traditional Knowledge of Nyi-shi (Daffla) tribe of Arunachal Pradesh. Indian J Tradit Knowl 2010; 9(1):26-37.

[17] Das M, Jaishi A, Sarma HN. Traditional Medicines of Herbal Origin Practice by the Adi Tribe of East Siang District of Arunachal Pradesh, India. Global J Res Med Plants Indigen Med 2013; 2(5):298-310.

[18] Arya OP, Mylliemngap W, Pandey A. Ethnomedicinal plants used by Adi community of Upper Siang District of Arunachal Pradesh in North-East India. Pleione 2020; 14(2):265-276. doi:10.26679/Pleione.14.2.2020.265-276.

[19] Kagyung R, Gajurel PR, Rethy P, Singh B. Ethnomedicinal plants used for gastro-intestinal diseases by Adi tribes of Dehang-Debang Biosphere Reserve in Arunachal Pradesh. Indian J Tradit Knowl 2010; 9(3):496-501.

[20] Bhattee SS, Beniwal BS. Coptis teeta Wall. - an Important and Valu-able Medicinal Plant of Arunachal Pradesh and its Cultivation. Indian Forester 1988; 114(5):251-260. doi:10.36808/if/1988/v114i5/9200.

[21] Neag MA, Mocan A, Echeverría J, Pop RM, Bocsan CI, Crişan G, et al. Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders. Front Pharmacol 2018;9:557. doi:10.3389/fphar.2018.00557,PMID:30186157.

[22] Perme N, Choudhury SN, Choudhury R, Natung T, De B. Medicinal Plants in Traditional Use at Arunachal Pradesh, India. Int J Phytop-harm 2015; 5(5):86-98.

[23] Ray S, Saini MK. Impending threats to the plants with medicinal value in the Eastern Himalayas Region: An analysis on the alternatives to its non-availability. Phytomed Plus 2022; 2(1):100151. doi:10.1016/j.phyplu.2021.100151.

[24] Javed F, Jabeen Q, Aslam N, Awan AM. Pharmacological evalua-tion of analgesic, anti-inflammatory and antipyretic activities of ethanolic extract of Indigofera argentea Burm. f. J Ethnopharmacol 2020;259:112966. doi:10.1016/j.jep.2020.112966,PMID:32418900.

[25] Wangpan T, Rongsak N, Taka T, Tesia P, Giba J, Tangjang S. Toxicity evaluation of some plants used in ethnofishery in Arunachal Pradesh, India. Toxicon 2023;228:107109. doi:10.1016/j.toxicon.2023.107109,PMID:37037274.

[26] Sharma M. An emic perspective on health and sickness:The Minyongs. In: Sengupta S ed. Indigenous health practices among the people of North East India. 1st ed. Delhi: Kalpaz Publications; 2018:179-187.

[27] Li FF, Zhuo JX, Liu B, Jarvis D, Long C. Ethnobotanical study on wild plants used by Lhoba people in Milin County, Tibet. J Ethnobiol Eth-nomed 2015; 11:23. doi:10.1186/s13002-015-0009-3,PMID:25879656.

[28] Moon M, Huh E, Lee W, Song EJ, Hwang DS, Lee TH, et al. Coptidis Rhizoma Prevents Heat Stress-Induced Brain Damage and Cogni-tive Impairment in Mice. Nutrients 2017; 9(10):1057. doi:10.3390/nu9101057,PMID:28946610.

[29] Goswami AK, Gogoi N, Shakya A, Sharma HK. Development and Vali-dation of High-Performance Thin-layer Chromatographic Method for Quantification of Berberine in Rhizomes of Coptis teeta Wall, an En-dangered Species Collected from Arunachal Pradesh, India. J Chro-matogr Sci 2019; 57(5):411-417. doi:10.1093/chromsci/bmz009,PMID:30753457.

[30] Liu TH, Zhang XM, Tian SZ, Chen LG, Yuan JL. Bioinformatics analysis of endophytic bacteria related to berberine in the Chinese medici-nal plant Coptis teeta Wall. 3 Biotech 2020; 10(3):96. doi:10.1007/s13205-020-2084-y,PMID:32099737.

[31] Nafees S, Akhtar J, Kaur J. Indian traditional medicinal plants in ophthalmic diseases. Avicenna J Phytomed 2022; 12(6):566-575. doi:10.22038/AJP.2022.20345,PMID:36583172.

[32] Lee MY, Lin MY, Chang YJ, Tseng YT, Huang IA, Huang WT, et al. Ef-ficacy and Safety of Modified Huang-Lian-Jie-Du Decoction Cream on Cancer Patients with Skin Side Effects Caused by EGFR Inhibition. Processes 2021; 9:1081. doi:10.3390/pr9071081.

[33] Wang J, Wang L, Lou GH, Zeng HR, Hu J, Huang QW, et al. Coptidis Rhi-zoma: a comprehensive review of its traditional uses, botany, phyto-chemistry, pharmacology and toxicology. Pharm Biol 2019; 57(1):193-225. doi:10.1080/13880209.2019.1577466,PMID:30963783.

[34] Zhang D, Arunachalam K, Wang Y, Zhang Y, Yang J, Hein PP, et al. Evaluation on Antidiabetic Properties of Medicinal Plants from My-anmar. ScientificWorldJournal 2021; 2021:1424675. doi:10.1155/2021/1424675,PMID:34504407.

[35] Li T, Zhang D, Oo TN, San MM, Mon AM, Hein PP, et al. Investiga-tion on the Antibacterial and Anti-T3SS Activity of Traditional My-anmar Medicinal Plants. Evid Based Complement Alternat Med 2018; 2018:2812908. doi:10.1155/2018/2812908,PMID:30402120.

[36] Feng X, Yan D, Zhao KJ, Luo JY, Ren YS, Kong WJ, et al. Applications of microcalorimetry in the antibacterial activity evaluation of various Rhizoma coptidis. Pharm Biol 2011; 49(4):348-353. doi:10.3109/13880209.2010.523428,PMID:21284509.

[37] Shwe KT. Investigation of Antimicrobial Activity, Elemental Analysis and Isolation of organic compounds of Coptis teeta Wall. (Hkantauk). Dagon University Commemoration of 25th Anniversary Silver Jubilee Research Journal 2019; 9(2):28-33.

[38] Bora H, Kamle M, Chopra S, Kumar P. Evaluation of Phytochemical Components, Antioxidant, and Antibacterial Activities of Coptis teeta Walls. International Journal of Pharmaceutical Research & Allied Sci-ences 2022; 11(4):140-150. doi:10.51847/1JGpbyKz1k.

[39] Eaker EY, Sninsky CA. Effect of berberine on myoelectric activity and transit of the small intestine in rats. Gastroenterology 1989;96(6):1506-1513. doi:10.1016/0016-5085(89)90519-2, PMID:2714578.

[40] Tsai JC, Tsai S, Chang WC. Effect of ethanol extracts of three Chinese medicinal plants with anti-diarrheal properties on ion transport of the rat intestinal epithelia. J Pharmacol Sci 2004; 94(1):60-66. doi:10.1254/jphs.94.60,PMID:14745119.

[41] Liu LM, Liu J, Huang ZX, Yu XX, Zhang XY, Dou D, et al. Berberine improves endothelial function by inhibiting endoplasmic reticulum stress in the carotid arteries of spontaneously hypertensive rats. Biochem Biophys Res Commun 2015; 458(4):796-801. doi:10.1016/j.bbrc.2015.02.028, PMID:25686503.

[42] Guo ZT, Sun HR, Zhang HM, Zhang YF. Anti-hypertensive and renopro-tective effects of berberine in spontaneously hypertensive rats. Clin Exp Hypertens 2015; 37(4):332-339. doi:10.3109/10641963.2014.972560,PMID:25867076.

[43] Lau CW, Yao XQ, Chen ZY, Ko WH, Huang Y. Cardiovascular actions of berberine. Cardiovasc Drug Rev 2001; 19(3):234-244. doi:10.1111/j.1527-3466.2001.tb00068.x, PMID:11607041.

[44] Kong WJ, Wei J, Abidi P, Lin MH, Inaba S, Li C, et al. Berberine is a nov-el cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004; 10(12):1344-1351. doi:10.1038/nm1135,PMID:15531889.

[45] Yokozawa T, Ishida A, Cho EJ, Nakagawa T. The effects of Coptidis Rhizoma extract on a hypercholesterolemic animal model. Phy-tomedicine 2003; 10(1):17-22. doi:10.1078/094471103321648610,PMID:12622459.

[46] Goswami AK, Sharma HK, Shakya A. Evaluation of Analgesic and Anti-Inflammatory Activity of Standardized Methanolic Extract of Coptis Teeta ( Wall.) Rhizomes. Curr Trends Pharm Res 2017; 4(1):01-15.

[47] Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm DH. Effect of berberine on depression- and anxiety-like behaviors and activation of the noradr-energic system induced by development of morphine dependence in rats. Korean J Physiol Pharmacol 2012; 16(6):379-386. doi:10.4196/kjpp.2012.16.6.379,PMID:23269899.

[48] Kulkarni SK, Dhir A. Current investigational drugs for major de-pression. Expert Opin Investig Drugs 2009; 18(6):767-788. doi:10.1517/13543780902880850,PMID:19426122.

[49] Tan Y, Tang Q, Hu BR, Xiang JZ. Antioxidant properties of berberine on cultured rabbit corpus cavernosum smooth muscle cells injured by hydrogen peroxide. Acta Pharmacol Sin 2007; 28(12):1914-1918. doi:10.1111/j.1745-7254.2007.00705.x, PMID:18031604.

[50] Babbar OP, Chhatwal VK, Ray IB, Mehra MK. Effect of berberine chlo-ride eye drops on clinically positive trachoma patients. Indian J Med Res 1982;76(Suppl):83-88. PMID:7185757.

[51] Khosla PK, Neeraj VI, Gupta SK, Satpathy G. Berberine, a potential drug for trachoma. Rev Int Trach Pathol Ocul Trop Subtrop Sante Pub-lique 1992; 69:147-165. PMID:1344968.

[52] Ni YX, Liu AQ, Gao YF, Wang WW, Song YG, Wang LH, et al. Therapeu-tic Effect of Berberine on 60 Patients with Non-Insulin Dependent Diabetes Mellitus and Experimental Research. CJIM 1995; 1:91-95. doi:10.1007/BF02942756.

[53] Yin J, Xing HL, Ye JP. Efficacy of berberine in patients with type 2 dia-betes mellitus. Metabolism 2008; 57(5):712-717. doi:10.1016/j.me-tabol.2008.01.013,PMID:18442638.

[54] Shah BP, Patel DR, Shah SK. Ameliorative effect of ethanolic extract of Coptis teeta wall. roots in alloxan induced diabetic rats. Indian Drugs 2022; 59(11):81-87. doi:10.53879/id.59.11.13313.

[55] Chit K, Myint W, Thein K, Maw WW, Myint MM, Than A, et al. Cyclic AMP Phosphodiesterase Inhibitory Activity and Chemical Screen-ing of Four Medicinal Plants. Pharm Biol 2001; 39(3):181-183. doi:10.1076/phbi.39.3.181.5932.

[56] Abdul L, Abdul R, Sukul RR, Nazish S. Anti-inflammatory and Antihis-taminic Study of a Unani Eye Drop Formulation. Ophthalmol Eye Dis 2010; 2:17-22. doi:10.4137/oed.s3612,PMID:23861612.

[57] Goswami AK, Sharma HK, Gogoi N, Kashyap A, Gogoi B. In vitro Evalu-ation and Molecular Dynamics, DFT Guided Investigation of Anti-malarial Activity of Ethnomedicinally used Coptis teeta Wall. Comb Chem High Throughput Screen 2022; 25(2):292-306. doi:10.2174/1386207324666210118095503,PMID:33461455.

[58] Du H, Tang B, Cao S, Xi C, Li X, Zhang L, et al. Discrimination of the species and authenticity of Rhizoma Coptidis based on stable isotope and multielement fingerprinting and multivariate statistical analysis. Anal Bioanal Chem 2019; 411(13):2827-2837. doi:10.1007/s00216-019-01723-3,PMID:30982927.

[59] Latif A, Razique A, Sukulb ARR, Zuberi RH. Phytochemical and Physico-chemical study of Coptis teeta Wall.: An effective drug of choice in ocular ailments. Eur J Integr Med 2008; 1(supp 1):22-23. doi:10.1016/j.eujim.2008.08.128.

[60] Chen HT, Fan G, He Y. Species evolution and quality evaluation of four Coptis herbal medicinal materials in Southwest China. 3 Biotech 2017; 7(1):62. doi:10.1007/s13205-017-0679-8,PMID:28444606.

[61] Li D, Zhou L, Wang Q, He Y. Determination of organic acids for quality evaluation in Coptis herbs by ion chromatography. 3 Bio-tech 2018; 8(6):285. doi:10.1007/s13205-018-1300-5,PMID:29881663.

[62] Meng FC, Wang L, Zhang J, Yin ZQ, Zhang QW, Ye WC. Non-alkaloid chemical constituents from the rhizome of Coptis teeta. J Chin Pharm Univ 2013; 44(4):307-310.

[63] Chen Y, Qi LM, Zhong FR, Li YR, Ke WJ, Ma YT. Integrated metabolomics and ligand fishing approaches to screen the hypoglycemic ingredients from four Coptis medicines. J Pharm Biomed Anal 2021;192:113655. doi:10.1016/j.jpba.2020.113655,PMID:33045623.

[64] Li JJ, Fan G, He Y. Predicting the current and future distribution of three Coptis herbs in China under climate change conditions, using the Max-Ent model and chemical analysis. Sci Total Environ 2020;698:134141. doi:10.1016/j.scitotenv.2019.134141,PMID:31505366.

[65] Fan G, Tao LH, Yue QH, Kuang TT, Tang C, Yang YD, et al. Metabolic discrimination of rhizoma coptidis from different species using 1H NMR spectroscopy and principal component analysis. Planta Med 2012; 78(6):641-648. doi:10.1055/s-0031-1298240,PMID:22314415.

[66] Singh B, Sharma RA. Coptis Species. Chapter 2.32. Secondary metab-olites of medicinal plants:ethnopharmacological properties, biologi-cal activity and production strategies. Wiley-VCH Verlag GmbH & Co. KgaA 2020;doi:10.1002/9783527825578.

[67] Li JJ, Zhao AP, Li DM, He Y. Comparative study of the free amino acid compositions and contents in three different botanical origins of Coptis herb. Biochem Sys Ecol 2019; 83:117-120. doi:10.1016/j.bse.2019.01.012.

[68] Mukherjee D, Chakraborty S. Coptis Teeta: Conservation and Cultiva-tion Practice - A Rare Medicinal Plant on Earth. Curr Inves Agri Curr Res 2019; 6(4):845-851. doi:10.32474/CIACR.2019.06.000244.

[69] Mishra MK.An insight into Coptis Teeta wall., an endangered me-dicinal plant and its conservation strategies. In: Mishra MK, Kumari N (eds). Plants for immunity and conservation strategies. Singapore: Springer; 2023:45-56. doi:10.1007/978-981-99-2824-8_3.